JPRN-UMIN000014287
Completed
未知
Research for objective evaluation of efficacy of anti-Parkinson's drug with repetitive transcranial magneticstimulation in Parkinson's disease - objective evaluation of efficacy of anti-Parkinson's drug with repetitive transcranial magnetic stimulation
niversity of Tokyo Hospital0 sites30 target enrollmentJune 18, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Parkinson'
- Sponsor
- niversity of Tokyo Hospital
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •In patients with internal metal such as cardiac pace maker, drug delivery pump or DBS, cerebral stroke, brain injury, brain tumor, epilepsy, psychiatric disorder, pregnant females, or those contemplating pregnancy. And people whom the investigators evaluate as approved.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluating the contribution of artificial intelligence to improvement of health outcomes in an mHealth programmeHealth Condition 1: O00-O9A- Pregnancy, childbirth and the puerperiumCTRI/2023/02/049472Google India Pvt. Ltd.
Completed
Phase 1
The efficacy determination and evaluation on the acute cutaneous tolerance of abalone extract (Part: Evaluation on the acute cutaneous tolerance of Abalone extractHealthy Thai male and female volunteers (20-60 years old)Skin irritation, Patch testTCTR20220210002Phuket Abalone Farm Co., Ltd33
Not yet recruiting
Not Applicable
It is a study to see the effect of erector spinae plane block in post herpetic neuralgia patients.CTRI/2022/08/044958Pt BD Sharma PGIMS Rohtak
Completed
Not Applicable
Prospective study to assess the effectiveness of an integrative primary care approach versus standard primary care management of chronic musculoskeletal pain.NL-OMON36897ouis Bolk Instituut268
Not yet recruiting
Phase 1
A study to assess effectiveness of social support group among cervical cancer patients and their caregivers.Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecifiedCTRI/2019/07/020057PGIMERChandigrah